Valuation GC Genome Corporation

Stocks

End-of-day quote Korea S.E. Other stock markets 22/06/2026			5-day change	1st Jan Change
4,860.00 ^KRW	+0.21%		-8.82%	-28.74%

12-09	GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy	CI
12/06/25	GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027
Market Cap ¹	161,298	114,943	-
Change	-	-28.74%	-
Enterprise Value (EV) ¹	161.3	55.54	46.14
Change	-	-65.57%	-16.92%
P/E	36.9x	-	-
PBR	-	-	-
PEG	-0x	-	-
Capitalization / Revenue	-	2.95x	2.36x
EV / Revenue	-	1.42x	0.95x
EV / EBITDA	-	-	-
EV / EBIT	-	13.9x	6.59x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ³	-	-	-
Rate of return	-	-	-
EPS ³	185	-	-
Distribution rate	-	-	-
Net sales ¹	-	39	48.8
EBITDA	-	-	-
EBIT ¹	-	4	7
Net income	4.044	-	-
Net Debt ¹	-	-59.4	-68.8
Reference price ³	6,820.00	4,860.00	4,860.00
Nbr of stocks (in thousands)	23,651	23,651	-
Announcement Date	16/03/26	-	-

¹KRW in Million²KRW in Billions³KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GC GENOME CORPORATION	-	1.42x	-	-	74.93M
NATERA, INC.	-139.71x	11.48x	-158.84x	-.--%	33.14B
LABCORP HOLDINGS INC.	17.77x	1.74x	10.03x	1.14%	20.98B
SONIC HEALTHCARE LIMITED	16.09x	1.28x	7.26x	5.41%	6.95B
RADNET, INC.	275.59x	-	-	-	4.23B
DR. LAL PATHLABS LIMITED	53.92x	9.52x	33.43x	0.86%	2.9B
GENEDX HOLDINGS CORP.	-19.69x	-	-	-	1.75B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	33.69x	1.47x	11.96x	1.6%	1.68B
DIAN DIAGNOSTICS GROUP CO.,LTD.	28.61x	1.15x	9.52x	0.88%	1.65B
FLEURY S.A.	11.74x	1.25x	4.87x	6.44%	1.58B
Average	30.89x	3.66x	-11.68x	2.33%	7.49B
Weighted average by Cap.	-36.57x	6.67x	-70.61x	1.14%